AI Identifies Key Alzheimer’s Gene, Opening Door to New Treatments

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-05-16 04:01:02

Researchers at the University of California, San Diego have Leveraged artificial intelligence to pinpoint PHGDH as a causative gene in Alzheimer’s disease. The breakthrough, published in Cell, redefines previous assumptions about the gene’s role—shifting from biomarker to mechanistic driver of neurodegeneration.

The discovery reveals how PHGDH disrupts transcriptional regulation in the brain, leading to spontaneous Alzheimer’s pathology. This paradigm shift enables targeted therapeutic development, with Nvidia highlighting the potential for AI-driven drug discovery pipelines to accelerate treatment options.

By:

Log in to Reply

NVIDIA Advances AI-Driven Digital Twins for Enhanced CFD Simulations

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.